In these studies, we demonstrate that BET proteins regulate MYC levels in prostate cancer models and the BET inhibitor, I-BET762, potently decreases MYC expression in cell lines and a patient-derived model with high MYC expression. This evidence concerns the gene MYC and Familial prostate cancer.